<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2018-01-17" updated="2020-01-02">
  <drugbank-id primary="true">DB13966</drugbank-id>
  <name>Isopropyl myristate</name>
  <description>Isopropyl myristate is a moisturizer with polar characteristics used in cosmetics and topical medical preparations to ameliorate the skin absorption. Isopropyl myristate has been largely studied and impulsed as a skin penetration enhancer.[A178078]&#13;
&#13;
At the moment the primary usage for which isopropyl myristate is formally indicated is as the active ingredient in a non-prescription pediculicide rinse [A32333, L1964, L1966].</description>
  <cas-number>110-27-0</cas-number>
  <unii>0RE8K4LNJS</unii>
  <average-mass>270.4507</average-mass>
  <monoisotopic-mass>270.255880332</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32330</ref-id>
        <pubmed-id>19423676</pubmed-id>
        <citation>Authors unspecified: Update on treatments for head lice. Drug Ther Bull. 2009 May;47(5):50-2. doi: 10.1136/dtb.2009.04.0014.</citation>
      </article>
      <article>
        <ref-id>A32332</ref-id>
        <pubmed-id>18563737</pubmed-id>
        <citation>Liu P, Cettina M, Wong J: Effects of isopropanol-isopropyl myristate binary enhancers on in vitro transport of estradiol in human epidermis: a mechanistic evaluation. J Pharm Sci. 2009 Feb;98(2):565-72. doi: 10.1002/jps.21459.</citation>
      </article>
      <article>
        <ref-id>A32333</ref-id>
        <pubmed-id>17942025</pubmed-id>
        <citation>Kaul N, Palma KG, Silagy SS, Goodman JJ, Toole J: North American efficacy and safety of a novel pediculicide rinse, isopropyl myristate 50% (Resultz). J Cutan Med Surg. 2007 Sep-Oct;11(5):161-7. doi: 10.2310/7750.2007.00045.</citation>
      </article>
      <article>
        <ref-id>A32335</ref-id>
        <pubmed-id>22943314</pubmed-id>
        <citation>Barnett E, Palma KG, Clayton B, Ballard T: Effectiveness of isopropyl myristate/cyclomethicone D5 solution of removing cuticular hydrocarbons from human head lice (Pediculus humanus capitis). BMC Dermatol. 2012 Sep 3;12:15. doi: 10.1186/1471-5945-12-15.</citation>
      </article>
      <article>
        <ref-id>A178078</ref-id>
        <pubmed-id>28132900</pubmed-id>
        <citation>Eichner A, Stahlberg S, Sonnenberger S, Lange S, Dobner B, Ostermann A, Schrader TE, Hauss T, Schroeter A, Huster D, Neubert RH: Influence of the penetration enhancer isopropyl myristate on stratum corneum lipid model membranes revealed by neutron diffraction and (2)H NMR experiments. Biochim Biophys Acta Biomembr. 2017 May;1859(5):745-755. doi: 10.1016/j.bbamem.2017.01.029. Epub 2017 Jan 26.</citation>
      </article>
    </articles>
    <textbooks>
      <textbook>
        <ref-id>T151</ref-id>
        <isbn>9780323292658</isbn>
        <citation>Kathy Moscou, Karen Snipe (2014). Pharmacology for Pharmacy Technicians. Elsevier Health Sciences.</citation>
      </textbook>
    </textbooks>
    <links>
      <link>
        <ref-id>L1963</ref-id>
        <title>Cosmetic Ingredient Review: Amended Safety Assessment of Alkyl Esters as Used in Cosmetics</title>
        <url>https://www.cir-safety.org/sites/default/files/alkyle122012tent_faa_final%20for%20posting.pdf</url>
      </link>
      <link>
        <ref-id>L1964</ref-id>
        <title>Canadian Paediatric Society: Head Lice Infestations - A clinical update</title>
        <url>https://www.cps.ca/en/documents/position/head-lice</url>
      </link>
      <link>
        <ref-id>L1966</ref-id>
        <title>Resultz: Why Resultz is the Best Choice For Your Patients</title>
        <url>https://resultz.ca/why-resultz-is-the-best-choice-for-your-patients/</url>
      </link>
      <link>
        <ref-id>L1969</ref-id>
        <title>ECHA Registration Dossier: Isopropyl Myristate</title>
        <url>https://echa.europa.eu/registration-dossier/-/registered-dossier/16077/7/2/3</url>
      </link>
      <link>
        <ref-id>L1973</ref-id>
        <title>NIH Toxnet: Isopropyl Myristate</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+626</url>
      </link>
      <link>
        <ref-id>L1978</ref-id>
        <title>Journal of the American College of Toxicology: Final Report on the Safety Assessment of Myristyl Myristate and Isopropyl Myristate</title>
        <url>http://www.beauty-review.nl/wp-content/uploads/2014/05/Final-report-on-the-safety-assessment-of-myristyl-myristate-and-isopropyl-myristate.pdf</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>The primary medical indication for which isopropyl myristate is formally used as an active ingredient in a patient care product is as a non-prescription pediculicide rinse [A32330].</indication>
  <pharmacodynamics>Isopropyl myristate is an emollient vehicle that is effective at enhancing the penetration of other medical agents that may be incorporated into the vehicle as active agents [L1963]. In one study, a 50:50 isopropanol-isopropyl myristate binary enhancer synergistically increased the transport of estradiol across a two-layer human epidermis in vitro [A32332].</pharmacodynamics>
  <mechanism-of-action>As a pediculicide, isopropyl myristate is capable of physically coating the exoskeleton bodies of lice [L1964, L1966, A32333, A32335]. This physical coating subsequently immobilizes the lice and works to dissolve the wax covering on the insect exoskeleton and blocks the insects' airways, leading to death by dehydration [L1964, L1966, A32333, A32335]. Although this physical action of isopropyl myristate results in little lice resistance (given the lack of immunologic or chemical activity in this mechanism of action), the substance is also not ovicidal, which means any eggs that may have been laid by lice would not be affected [L1964, L1966, A32333, A32335]. Moreover, isopropyl myristate is capable of eliciting its pediculicide action in a contact time of only 10 minutes per each necessary administration [L1964, L1966, A32333, A32335]. </mechanism-of-action>
  <toxicity>Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].</toxicity>
  <metabolism>Any isopropyl myristate that is absorbed is likely to be hydrolyzed to its component compounds of isopropylalcohol and myristic acid [L1973].</metabolism>
  <absorption>Dermal absorption of isopropyl myristate is predicated to be 0.00020 mg/cm2/event, which is considered a very low absorption rate [L1969]. In a study, topically applied isopropyl myristate was largely retained in the stratum corneum [A32332]. It was not detected in the receptor fluid of flow-through diffusion cells in in-vitro skin permeation experiments using human epidermis (stratum corneum and viable epidermis) and dermis of varying thickness [A32332]. </absorption>
  <half-life>Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].</half-life>
  <protein-binding>Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].</protein-binding>
  <route-of-elimination>Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].</route-of-elimination>
  <volume-of-distribution>Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].</volume-of-distribution>
  <clearance>Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].</clearance>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">1-Methylethyl tetradecanoate</synonym>
    <synonym language="english" coder="usan">Isopropyl myristate</synonym>
    <synonym language="english" coder="">Isopropyl tetradecanoate</synonym>
  </synonyms>
  <products>
    <product>
      <name>Resultz</name>
      <labeller>Aralez Pharmaceuticals Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02279592</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-09-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Secol</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00351385</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1975-12-31</started-marketing-on>
      <ended-marketing-on>2012-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Estergel</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Resultz</name>
      <ingredients>Isopropyl myristate</ingredients>
    </mixture>
    <mixture>
      <name>Secol</name>
      <ingredients>Isopropyl myristate + Lanolin + Mineral oil</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Fatty Acids</category>
      <mesh-id>D005227</mesh-id>
    </category>
    <category>
      <category>Lipids</category>
      <mesh-id>D008055</mesh-id>
    </category>
    <category>
      <category>Myristic Acids</category>
      <mesh-id>D009227</mesh-id>
    </category>
    <category>
      <category>Scabicides and Pediculicides</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Solution</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes>
    <ahfs-code>84:04.12</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB13966.pdf?1522683549</fda-label>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB13966.pdf?1522363288</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>7.02</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-6.4</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.10e-04 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>6.29</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>propan-2-yl tetradecanoate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>isopropyl myristate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>270.4507</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>270.255880332</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CCCCCCCCCCCCCC(=O)OC(C)C</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C17H34O2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C17H34O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-17(18)19-16(2)3/h16H,4-15H2,1-3H3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>AXISYYRBXTVTFY-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>26.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>81.82</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>36.05</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>14</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>6628</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>90027</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>7751</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Isopropyl_myristate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL207602</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB13966</drugbank-id>
        <name>Isopropyl myristate</name>
      </left-element>
      <right-element>
        <drugbank-id>DB02325</drugbank-id>
        <name>Isopropyl alcohol</name>
      </right-element>
      <enzymes>
        <enzyme>
          <drugbank-id>BE0004740</drugbank-id>
          <name>Carboxylesterase</name>
          <uniprot-id>Q6LAP9</uniprot-id>
        </enzyme>
      </enzymes>
    </reaction>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB13966</drugbank-id>
        <name>Isopropyl myristate</name>
      </left-element>
      <right-element>
        <drugbank-id>DB08231</drugbank-id>
        <name>Myristic acid</name>
      </right-element>
      <enzymes>
        <enzyme>
          <drugbank-id>BE0004740</drugbank-id>
          <name>Carboxylesterase</name>
          <uniprot-id>Q6LAP9</uniprot-id>
        </enzyme>
      </enzymes>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>